Media News
Genzyme’s News—One Year Archive
Genzyme
| June 25, 2009 | Genzyme Reports Progress Related to Allston Plant | | June 16, 2009 | Genzyme Temporarily Interrupts Production at Allston Plant | | June 12, 2009 | Genzyme Receives European Approval of Renvela for Patients with Chronic Kidney Disease | | June 2, 2009 | Genzyme Completes Transaction with Bayer HealthCare | | May 29, 2009 | Genzyme Receives Positive Opinion for European Approval of Mozobil | | May 21, 2009 | Genzyme Submits All Information Requested by FDA for Lumizyme | | May 20, 2009 | Genzyme and Isis Announce that Mipomersen Phase 3 Study in Patients with Homozygous Familial Hypercholesterolemia Met Primary Endpoint | | May 6, 2009 | Genzyme Provides Outlook for Long-Term Growth at its Analyst Day Meeting | | April 22, 2009 | Genzyme Reports Solid Financial Results for the First Quarter of 2009 | | March 31, 2009 | Genzyme and Bayer HealthCare Enter New Strategic Agreement | | March 19, 2009 | Genzyme Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease | | March 2, 2009 | Genzyme Receives Complete Response Letter from FDA on Lumizyme Application | | February 26, 2009 | European Authorities Approve Larger-Scale Production of Genzyme’s Myozyme | | February 26, 2009 | FDA Approves Genzyme’s Synvisc-One for Osteoarthritis of the Knee | | February 20, 2009 | Study of Genzyme Oral Compound for Gaucher Disease Meets Primary Endpoint | | February 19, 2009 | Genzyme Receives Positive Opinion on Myozyme from CHMP | | February 11, 2009 | Strong Fourth Quarter for Genzyme Concludes Productive Year | | February 3, 2009 | Genzyme Center Wins Prestigious Architecture Award | | January 13, 2009 | Genzyme Reports Strong Fourth-Quarter and 2008 Revenue Growth | | January 12, 2009 | Genzyme and Isis Begin New Clinical Trials of Mipomersen | | January 7, 2009 | Genzyme to Present at 27th Annual JPMorgan Healthcare Conference | | December 15, 2008 | FDA Approves Genzyme’s Mozobil | | December 11, 2008 | Progress by Genzyme, the Broad Institute and Medicines for Malaria Ventures Toward Developing Drug Candidates for Malaria Highlighted at Tropical Medicine Meeting | | December 9, 2008 | FDA Advisory Committee Unanimously Recommends Approval of Genzyme’s Synvisc-One | | December 8, 2008 | Genzyme Reports Clolar® Data Further Supporting Potential of Product to Treat Adult AML Patients | | December 5, 2008 | FDA Advisory Committee to Discuss Genzyme’s Synvisc-One PMA on Tuesday | | November 24, 2008 | Genzyme Seeks U.S. Approval for Clolar® to Treat Adult AML | | November 17, 2008 | Genzyme and the International Center for Genetic Engineering and Biotechnology Form Collaboration to Advance Treatments for Neglected Diseases | | November 17, 2008 | Myozyme Produced at the 2000 L Bioreactor Scale to Receive Accelerated Approval | | November 4, 2008 | Genzyme and Osiris Partner to Develop and Commercialize First-in-Class Adult Stem Cell Products | | October 22, 2008 | Study Results: Multiple Sclerosis Patients Have Significant and Sustained Reduction in Disability and Risk Of Relapse On Alemtuzumab Versus Approved Therapy, Rebif® | | October 22, 2008 | Genzyme Reports Strong Third-Quarter Sales and Earnings Growth | | October 17, 2008 | FDA Advisory Panel to Discuss Genzyme’s Myozyme BLA on Tuesday | | October 15, 2008 | Genzyme Begins Enrollment in Post-Marketing Study to Evaluate Use of Low Dose Fabrazyme Treatment for Fabry Disease | | October 9, 2008 | Genzyme Recognized by Scientists as a Top Employer | | September 23, 2008 | Mozobil Receives Priority Review with FDA Action Expected by Year End; Synvisc-ONE FDA Action also Expected by Year End | | September 22, 2008 | Genzyme Marks Grand Opening of New Science Center; Among the First Research Laboratories to Earn Gold LEED Rating | | August 25, 2008 | Genzyme Corporation and Medicines for Malaria Venture Announce New Collaboration with Advinus Therapeutics to Accelerate Discovery of Novel Therapies for Malaria | | August 6, 2008 | Genzyme and Isis Begin Second Phase 3 Trial of Mipomersen | | July 23, 2008 | Genzyme Reports Strong Second-Quarter Growth | | July 17, 2008 | Genzyme Corporation and PTC Therapeutics Announce Collaboration on Small Molecule for Genetic Diseases | | June 24, 2008 | Genzyme and Isis complete licensing of mipomersen | | June 17, 2008 | Genzyme Files Applications for Approval of Mozobil in the United States and Europe | | May 7, 2008 | Preliminary Results from Phase 2 Genzyme Study | | April 22, 2008 | Genzyme to Build New R&D Center in Beijing | | March 19, 2008 | Genzyme Withdraws Bioenvision’s European Filing of Evoltra® in Elderly AML Patients |
|
|
|
Home
